On November 3, a federal district court issued a monumental decision endorsing an expansive view of who is a “patient” of a 340B program covered entity eligible to receive a 340B drug. In Genesis ...
The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7. The lawsuit was ...
ISPOR, the professional society for health economics and outcomes research, held a session this evening, "Defining Patient-Centeredness and Engagement in Health Economics and Outcomes Research: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results